Home › Funds › Decheng Capital LLC › NUVB

Decheng Capital LLC position in NUVB

NUVATION BIO INC · Health Care

Decheng Capital LLC reported holding 25,954,439 shares of NUVB (NUVATION BIO INC) in its Q3 2026 13F filing — a position valued at US$145.3M, representing 21.22% of its reported portfolio and ranking #2 among its reported holdings. Decheng Capital LLC has disclosed NUVB holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)25.95M sh
Reported value held$145.34M
Portfolio Weight21.22%
First reportedQ2 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Decheng Capital LLC's NUVB position evolved

Decheng Capital LLC first disclosed a stake in NUVB in Q2 2024 at 6,950,239 shares (US$20.3M). The position peaked in Q4 2025 at 25,954,439 shares, worth US$232.6M. Across 10 filings, Decheng Capital LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 25,954,439 shares valued at US$145.3M. Notable position changes include a 273% increase in Q3 2024 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 6.95M $20.29M New
Q3 2024 25.95M $59.44M Add
Q4 2024 25.95M $69.04M Hold
Q1 2025 25.95M $45.68M Hold
Q2 2025 25.95M $50.61M Hold
Q3 2025 25.95M $96.03M Hold
Q4 2025 25.95M $232.55M Hold
Q1 2026 25.95M $111.34M Hold
Q2 2026 25.95M $147.42M Hold
Q3 2026 25.95M $145.34M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVB and 13F data

NUVB (NUVATION BIO INC) is a Health Care company. 54 other funds we track also report a position in NUVB — the largest reported positions include Context Capital Management, LLC (US$53.1M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$43.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVB

All NUVB fund holders →

FAQ

How long has Decheng Capital LLC held NUVB?

Decheng Capital LLC has disclosed NUVB holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Decheng Capital LLC's current position in NUVB?

As of Q3 2026, Decheng Capital LLC holds 25.95M shares of NUVB (NUVATION BIO INC), valued at $145.34M, representing 21.22% of its reported portfolio and ranking #2.

Has Decheng Capital LLC been buying or selling NUVB?

In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in NUVB. The position peaked in Q4 2025 at 25.95M shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Context Capital Management, LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.